colitis

Cannabinoids as novel anti-inflammatory drugs

ABSTRACT Cannabinoids have been shown to regulate the tissue response to excessive inflammation in the colon, mediated by both dampening smooth-muscular irritation caused by inflammation and suppressing proinflammatory cytokines, thus controlling the cellular pathways leading to inflammatory responses. These results strongly suggest that modulation of the physiological activity of the cannabinoid system during colonic inflammation …

Cannabinoids as novel anti-inflammatory drugs Read More »

Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis.

ABSTRACT CBD targets enteric reactive gliosis, counteracts the inflammatory environment induced by LPS in mice and in human colonic cultures derived from UC patients. These actions lead to a reduction of intestinal damage mediated by PPARgamma receptor pathway. Our results therefore indicate that CBD indeed unravels a new therapeutic strategy to treat inflammatory bowel diseases. …

Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis. Read More »

Scroll to Top
Scroll to Top